Company Filing History:
Years Active: 2020-2024
Title: The Innovative Contributions of William Jia
Introduction
William Jia is a prominent inventor based in Burnaby, Canada. He has made significant contributions to the field of biotechnology, particularly in cancer research. With a total of 3 patents to his name, his work focuses on developing novel therapeutic approaches to combat cancer.
Latest Patents
William Jia's latest patents include groundbreaking innovations. One of his patents is titled "Oncolytic herpes simplex virus vectors expressing immune system-stimulatory molecules." This patent describes an HSV vector that comprises an expression cassette for one or more of IL12, IL15, and hIL15Receptor alpha subunit. Another notable patent is "Compositions and methods for inhibiting CD279 interactions." This patent discloses methods and compositions for inhibiting interactions between programmed Death-1 protein (CD279) and programmed death-ligand 1 (PD-L1) and/or programmed death-ligand 2 (PD-L2). Additionally, it includes methods for increasing IL-2 levels in a cell and for preventing, treating, or ameliorating the effects of cancer in a subject.
Career Highlights
William Jia is currently associated with Virogin Biotech Canada Ltd., where he continues to advance his research and innovations. His work has been instrumental in developing therapies that harness the immune system to fight cancer. His dedication to research and innovation has positioned him as a key figure in the biotechnology sector.
Collaborations
William Jia collaborates with esteemed colleagues, including Xuexian Bu and I-Fang Lee. These collaborations enhance the scope and impact of his research, fostering a collaborative environment that drives innovation.
Conclusion
William Jia's contributions to biotechnology and cancer research are noteworthy. His innovative patents and collaborative efforts reflect his commitment to advancing medical science. His work continues to inspire and pave the way for future breakthroughs in cancer treatment.